Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Rising incidence of Mycoplasma pneumoniae pneumonias in a tertiary paediatric centre: implications for antibiotic therapy

L. Bača, L. Slováková, J. Vočková, K. Doležalová

. 2025 ; 33 (1) : 77-79. [pub] -

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25011612

Digitální knihovna NLK
Zdroj

E-zdroje Online Plný text

NLK Free Medical Journals od 2004
ProQuest Central od 2009-03-01 do Před 6 měsíci
Medline Complete (EBSCOhost) od 2006-03-01 do Před 6 měsíci
Nursing & Allied Health Database (ProQuest) od 2009-03-01 do Před 6 měsíci
Health & Medicine (ProQuest) od 2009-03-01 do Před 6 měsíci
Public Health Database (ProQuest) od 2009-03-01 do Před 6 měsíci
ROAD: Directory of Open Access Scholarly Resources od 1993

OBJECTIVES: The aim of this study is to determine the incidence of Mycoplasma pneumoniae pneumonia (MPP) in children and adolescents in Prague, Czech Republic, between January and July 2024, and to compare the findings with data from the preceding period. METHODS: A retrospective analysis of data of paediatric patients at our single tertiary care facility was conducted. Two distinct patient cohorts were subjected to analysis: the first comprising individuals who had been hospitalised between January 2019 and July 2024, and the second consisting of outpatients who had been treated during the periods of January to July 2023 and January to July 2024. RESULTS: A 12.3-fold increase in the number of outpatients diagnosed with MPP was observed between January and July 2024 in comparison to the same period in 2023, with 111 cases reported in 2024 versus 9 cases in 2023. A total of 23 patients were hospitalised with MPP between January 2019 and July 2024, with 15 of these hospitalisations having occurred between January and July 2024. The median age was 12 years, with an age range of 1 to 17 years. The majority of cases presented with a high fever, chest pain, and required oxygen support. A failure of the clarithromycin treatment was observed, resulting in 19.48% of doxycycline prescriptions being issued due to a prior failure of clarithromycin treatment. During the monitoring period, no cases of treatment failure with doxycycline were documented. CONCLUSION: The present study demonstrates an emerging trend of increased incidence of Mycoplasma pneumoniae pneumonia in the paediatric population during the initial seven months of 2024 in the Czech Republic. Doxycycline has been demonstrated to be the optimal antibiotic for the treatment of MPP and in accordance with the prevailing practice in other states it should be included in the therapeutic regimen even in children under the age of eight. The authors put forward recommendations for the implementation of measures aimed at reducing the negative impact of MPP on public health.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25011612
003      
CZ-PrNML
005      
20250527091426.0
007      
ta
008      
250506s2025 xr f 000 0|eng||
009      
AR
024    7_
$a 10.21101/cejph.a8434 $2 doi
035    __
$a (PubMed)40293833
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Bača, Ľuboš $u Department of Paediatrics, First Faculty of Medicine, Charles University, and Thomayer University Hospital, Prague, Czech Republic $7 xx0253625
245    10
$a Rising incidence of Mycoplasma pneumoniae pneumonias in a tertiary paediatric centre: implications for antibiotic therapy / $c L. Bača, L. Slováková, J. Vočková, K. Doležalová
520    9_
$a OBJECTIVES: The aim of this study is to determine the incidence of Mycoplasma pneumoniae pneumonia (MPP) in children and adolescents in Prague, Czech Republic, between January and July 2024, and to compare the findings with data from the preceding period. METHODS: A retrospective analysis of data of paediatric patients at our single tertiary care facility was conducted. Two distinct patient cohorts were subjected to analysis: the first comprising individuals who had been hospitalised between January 2019 and July 2024, and the second consisting of outpatients who had been treated during the periods of January to July 2023 and January to July 2024. RESULTS: A 12.3-fold increase in the number of outpatients diagnosed with MPP was observed between January and July 2024 in comparison to the same period in 2023, with 111 cases reported in 2024 versus 9 cases in 2023. A total of 23 patients were hospitalised with MPP between January 2019 and July 2024, with 15 of these hospitalisations having occurred between January and July 2024. The median age was 12 years, with an age range of 1 to 17 years. The majority of cases presented with a high fever, chest pain, and required oxygen support. A failure of the clarithromycin treatment was observed, resulting in 19.48% of doxycycline prescriptions being issued due to a prior failure of clarithromycin treatment. During the monitoring period, no cases of treatment failure with doxycycline were documented. CONCLUSION: The present study demonstrates an emerging trend of increased incidence of Mycoplasma pneumoniae pneumonia in the paediatric population during the initial seven months of 2024 in the Czech Republic. Doxycycline has been demonstrated to be the optimal antibiotic for the treatment of MPP and in accordance with the prevailing practice in other states it should be included in the therapeutic regimen even in children under the age of eight. The authors put forward recommendations for the implementation of measures aimed at reducing the negative impact of MPP on public health.
650    _2
$a lidé $7 D006801
650    12
$a mykoplazmová pneumonie $x epidemiologie $x farmakoterapie $7 D011019
650    _2
$a dítě $7 D002648
650    _2
$a mladiství $7 D000293
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a předškolní dítě $7 D002675
650    12
$a antibakteriální látky $x terapeutické užití $7 D000900
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a incidence $7 D015994
650    _2
$a kojenec $7 D007223
650    _2
$a centra terciární péče $7 D062606
650    _2
$a Mycoplasma pneumoniae $7 D009177
650    _2
$a hospitalizace $x statistika a číselné údaje $7 D006760
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Slováková, Lea $u Department of Paediatrics, First Faculty of Medicine, Charles University, and Thomayer University Hospital, Prague, Czech Republic $7 xx0314254
700    1_
$a Vočková, Jitka $u Department of Paediatrics, First Faculty of Medicine, Charles University, and Thomayer University Hospital, Prague, Czech Republic $7 xx0332424
700    1_
$a Doležalová, Karolína $u Department of Paediatrics, First Faculty of Medicine, Charles University, and Thomayer University Hospital, Prague, Czech Republic $7 xx0237719
773    0_
$w MED00001083 $t Central European journal of public health $x 1210-7778 $g Roč. 33, č. 1 (2025), s. 77-79
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40293833 $y Pubmed
910    __
$a ABA008 $b B 1829 $c 562 $y p $z 0
990    __
$a 20250506 $b ABA008
991    __
$a 20250527091427 $b ABA008
999    __
$a ok $b bmc $g 2324863 $s 1248702
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 33 $c 1 $d 77-79 $e - $i 1210-7778 $m Central European journal of public health $n Cent Eur J Public Health $x MED00001083
LZP    __
$b NLK116 $a Pubmed-20250506

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...